Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder

Journal of Clinical Psychiatry

Volumn 77, Issue 7, 2016, Pages e855-e859

  Şimşek, Şeref ^a   Gençoǧlan, Salih ^b   Yüksel, Tuǧba ^a   Kaplan, Ibrahim ^a   Alaca, Rümeysa ^a  

^a DICLE UNIVERSITY   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN; HYDROCORTISONE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TREATMENT PLANNING; BLOOD; CASE CONTROL STUDY; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOLOGICAL RATING SCALE;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; HYDROCORTISONE; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES;

EID: 84980373446     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10146     Document Type: Article

References (39)

1. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Pauls DL, Alsobrook JP 2nd, Goodman W, et al. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;152(1):76-84.
3. Heyman I, Fombonne E, Simmons H, et al. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry. 2001;179(4):324-329.
4. Pauls DL. The genetics of obsessivecompulsive disorder: A review. Dialogues Clin Neurosci. 2010;12(2):149-163.
5. Samuels JF. Recent advances in the genetics of obsessive-compulsive disorder. Curr Psychiatry Rep. 2009;11(4):277-282.
6. Gothelf D, Aharonovsky O, Horesh N, et al. Life events and personality factors in children and adolescents with obsessive-compulsive disorder and other anxiety disorders. Compr Psychiatry. 2004;45(3):192-198.
7. Numakawa T, Suzuki S, Kumamaru E, et al. BDNF function and intracellular signaling in neurons. Histol Histopathol. 2010;25(2):237-258.
8. Graham DL, Krishnan V, Larson EB, et al. Tropomyosin-related kinase B in the mesolimbic dopamine system: Region-specific effects on cocaine reward. Biol Psychiatry. 2009;65(8):696-701.
9. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.
10. Lyons WE, Mamounas LA, Ricaurte GA, et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A. 1999;96(26):15239-15244.
11. Mamounas LA, Altar CA, Blue ME, et al. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci. 2000;20(2):771-782.
12. Martinowich K, Lu B. Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology. 2008;33(1):73-83.
13. Stein DJ, Daniels WM, Savitz J, et al. Brainderived neurotrophic factor: The neurotrophin hypothesis of psychopathology. CNS Spectr. 2008;13(11):945-949.
14. Hall D, Dhilla A, Charalambous A, et al. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet. 2003;73(2):370-376.
15. Dickel DE, Veenstra-VanderWeele J, Bivens NC, et al. Association studies of serotonin system candidate genes in early-onset obsessivecompulsive disorder. Biol Psychiatry. 2007;61(3):322-329.
16. Wendland JR, Kruse MR, Cromer KR, et al. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology. 2007;32(12):2543-2551.
17. Suliman S, Hemmings SM, Seedat S. Brainderived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci. 2013:7:55.
18. Maina G, Rosso G, Zanardini R, et al. Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study. J Affect Disord. 2010;122(1-2):174-178.
19. Dos Santos IM, Ciulla L, Braga D, et al. Symptom dimensional approach and BDNF in unmedicated obsessive-compulsive patients: An exploratory study. CNS Spectr. 2011;16(9):179-189.
20. Wang Y, Mathews CA, Li Y, et al. Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug- Treated OCD patients. J Affect Disord. 2011;133(1-2):305-310.
21. Findley DB, Leckman JF, Katsovich L, et al. Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents with Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2003;42(4):450-457.
22. Kluge M, Schüssler P, Künzel HE, et al. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res. 2007;41(11):928-933.
23. Gustafsson PE, Gustafsson PA, Ivarsson T, et al. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology. 2008;57(1-2):14-21.
24. Tapia-Arancibia L, Rage F, Givalois L, et al. Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol. 2004;25(2):77-107.
25. Liston C, Gan W-B. Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc Natl Acad Sci U S A. 2011;108(38):16074-16079.
26. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988.
27. Gökler B, Ünal F, Pehlivantürk B, et al. Reliability and Validity of Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version-Turkish Version (K-SADS-PL-T). Turk J Child Adolesc Ment Health. 2004;11(3):109-116.
28. Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844-852.
29. Yucelen AG, Rodopman-Arman A, Topcuoglu V, et al. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive- Compulsive Scale in an outpatient setting. Compr Psychiatry. 2006;47(1):48-53.
30. Kovacs M. The Children's Depression Inventory (CDI). Psychopharmacol Bull. 1985;21(4):995-998.
31. Oy B. The Children's Depression Inventory: validity and reliability study. Turk J Psychiatry. 1991;(2):132-136.
32. Fontenelle LF, Barbosa IG, Luna JV, et al. Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res. 2012;199(3):195-200.
33. Brambilla F, Perna G, Bussi R, et al. Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation. Psychoneuroendocrinology. 2000;25(3):301-310.
34. Coles ME, Heimberg RG, Frost RO, et al. Not just right experiences and obsessive-compulsive features: Experimental and self-monitoring perspectives. Behav Res Ther. 2005;43(2):153-167.
35. Holsboer F, Ising M. Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol. 2010;61(1):81-109, C1-C11.
36. Tata DA, Marciano VA, Anderson BJ. Synapse loss from chronically elevated glucocorticoids: Relationship to neuropil volume and cell number in hippocampal area CA3. J Comp Neurol. 2006;498(3):363-374.
37. Wellman CL. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol. 2001;49(3):245-253.
38. Della FP, Abelaira HM, Réus GZ, et al. Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model. Pharmacol Biochem Behav. 2012;103(2):395-402.
39. Leonard HL, Ale CM, Freeman JB, et al. Obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am. 2005;14(4):727-743.